Clinical Trials in Atlanta

Showing 8681-8700 of 19,805 trials

Life Steps for PrEP for Youth

NCT03805451

This is a formative study, designed to provide information required to tailor Life-Steps for Pre-Exposure Prophylaxis (PrEP), an evidence-based cognitive behavioral adherence intervention, to enhance PrEP uptake and adherence in high risk young men who have sex with men (YMSM) and young transgender women who have sex with men (YTWSM). Life-Steps for Pre-exposure prophylaxis (PrEP) is a manualized modular adherence intervention based on principles of cognitive-behavioral therapy (CBT), that allows for recipients of the intervention to focus on the greatest challenges that they perceive in maintaining optimal adherence to PrEP.

HIVPre-exposure ProphylaxisMedication Adherence

Fenway Community Health32 participantsStarted Sep 2019

Atlanta, Georgia, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

NCT03428217

Tthe primary objective of this study is to compare blinded Independent Radiology Committee (IRC)-adjudicated progression free survival (PFS) of patients treated with CB-839 + cabozantinib (CB-Cabo) versus placebo + cabozantinib (Pbo-Cabo) for advanced or metastatic clear-cell RCC (ccRCC).

Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma

Calithera Biosciences, Inc444 participantsStarted Apr 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +130 more locations

Life Steps for PrEP for Youth

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Find Trials by Condition in Atlanta

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

Assessment of Acute Disease to Reduce Imaging Costs

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

OPTIMIZE IDE for the Treatment of ACS

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)

Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants

The Medtronic TAVR 2.0 US Clinical Study

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Bioavailability of EPA + DHA in a SMEDS Formulation

The TREFOIL Concept 5 Year Clinical Investigation